SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer

SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer

BackgroundTriple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer owing to a lack of effective targeted therapy and acquired chemoresistance. Here, we explored the function and mechanism of shank-interacting protein-like 1 (SIPL1) in TNBC progression.MethodsSIPL1 expression wa...

Full description

Bibliographic Details
Main Authors: Juanjuan He, Jing Wang, Teng Li, Kunlun Chen, Songchao Li, Shaojin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Oncology
Subjects:
MAZ
SIPL1
triple-negative breast cancer
Akt
NF-κB
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.766790/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.766790/full

Similar Items